The Impact of Regulatory Frameworks
The global organ preservation market is a rapidly expanding sector within the healthcare industry. It encompasses the products, technologies, and services used to maintain the viability of organs between donation and transplantation. This market is a critical component of transplant medicine, enabling successful organ sharing over greater distances and extending the window for life-saving surgeries. Key drivers include the rising incidence of chronic diseases, an aging global population, and technological advancements in preservation techniques.
The global market size was estimated at approximately USD 273.03 billion in 2024 and is projected to reach around USD 513.96 billion by 2034, with a Compound Annual Growth Rate (CAGR) of about 6.53% during the forecast period. This growth is a testament to the increasing demand for effective transplant solutions and the continuous innovation in the field.
FAQs
How do regulatory bodies affect the market? Regulatory bodies, such as the FDA in the U.S., set strict standards for the safety and efficacy of preservation solutions and devices, which influences product development and market entry.
What is the role of the UNOS? The United Network for Organ Sharing (UNOS) in the U.S. manages the national organ transplant waiting list and organ allocation, directly impacting the demand for and utilization of preservation technologies.